The promise and harms of screening for plasma cell dyscrasias

The promise and harms of screening for plasma cell dyscrasias

Summary In this perspective, we highlight both the promise and harms of screening for plasma cell dyscrasias, as well as the implications of the use of mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of haematology 2023-03, Vol.200 (6), p.704-707
Hauptverfasser: Mohyuddin, Ghulam Rehman, Chakraborty, Rajshekhar, Scheffer Cliff, Edward R.
Format: Artikel
Sprache:eng
Schlagworte:
Hematology
Humans
mass spectrometry
Mass spectroscopy
Monoclonal gammopathy
Monoclonal Gammopathy of Undetermined Significance
Multiple Myeloma
Paraproteinemias
plasma cell dyscrasia
screening
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Summary In this perspective, we highlight both the promise and harms of screening for plasma cell dyscrasias, as well as the implications of the use of mass spectrometry for diagnosing monoclonal gammopathy of undetermined significance in routine practice.
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.18634